Age related changes of soluble Fas, Fas ligand and Bcl-2 in autoimmune thyroid diseases;Zmiany stȩżenia Fas, FasL oraz Bcl-2 w surowicy krwi zwia̧zane z wiekiem u pacjentów z autoimmunologicznymi chorobami tarczycy

Endokrynologia Polska

Volumn 58, Issue 6, 2007, Pages 492-495

  Myśliwiec, Janusz ^a   Okłota, Magdalena ^a   Nikołajuk, Agnieszka ^a   Górska, Maria ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Age; Graves' disease; Hashimoto's thyroiditis; sBcl 2; sFas; sFasL

Indexed keywords

FAS ANTIGEN; FAS LIGAND; PROTEIN BCL 2;

ADULT; AGING; APOPTOSIS; ARTICLE; AUTOIMMUNE THYROIDITIS; BLOOD; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMAN; MALE; MIDDLE AGED;

ADULT; AGING; ANTIGENS, CD95; APOPTOSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAS LIGAND PROTEIN; FEMALE; GRAVES DISEASE; HASHIMOTO DISEASE; HUMANS; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-BCL-2; THYROIDITIS, AUTOIMMUNE;

EID: 43549124621     PISSN: 0423104X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gupta S. Molecular mechanisms of apoptosis in the cells of the immune system in human aging. Immunol Rev 2005; 205: 114-129. (Pubitemid 40780181)
2. Hsu HC, Scott DK, Mountz JD. Impaired apoptosis and immune senescence-cause or effect? Immunol Rev 2005; 205: 130-146. (Pubitemid 40780182)
3. Kobayashi M, Yasui N, Ishimaru N i wsp. Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjogren's syndrome. Arthritis Rheum 2004; 50: 3974-3984. (Pubitemid 39643946)
4. Roths JB, Murphy ED, Eicher EM. A new mutation, gld, that produces lymphoproliferation and autoimmunity in C3H/HeJ mice. J Exp Med 1984; 159: 1-20. (Pubitemid 14186350)
5. Radvanyi LG, Raju LG, Spaner D i wsp. Interleukin-2 reverses the defect in activation-induced apoptosis in T cells from autoimmune lpr mice. Cell Immunol 1998; 183: 1-12. (Pubitemid 28216569)
6. Broadley SA, Deans J, Sawcer J i wsp. Autoimmune disease in first-degree relatives of patients with multiple sclerosis. Brain 2000; 123: 1102-1111. (Pubitemid 30312103)
7. Laurberg P, Jorgensen T, Perrild H i wsp. The Danish investigation on iodine intake and thyroid disease, DanThyr: status and perspectives. Eur J Endocrinol 2006; 155: 219-228. (Pubitemid 44269438)
8. Stassi G, Zeuner A, Di Liberto D i wsp. Fas-FasL in Hashimoto's thyroiditis. J Clin Immunol 2001; 21: 19-23. (Pubitemid 32281583)
9. Hiromatsu Y, Hoshino T, Yagita H. Functional Fas ligand expression in thyrocytes from patients with Graves' disease. J Clin Endocrinol Metab 1999; 84: 2896-2899.
10. Hammond LJ, Palazzo FF, Shattoc M i wsp. Thyrocyte targets and effectors of autoimmunity: a role for death receptor? Thyroid 2001; 11: 919-927. (Pubitemid 33020178)
11. Salmaso C, Bagnasco M, Pesce G i wsp. Regulation of apop-tosis in endocrine autoimmunity: insight from Hashimoto's thyroiditis and Graves' disease. Ann N Y Acad Sci 2002; 966: 496-501. (Pubitemid 34729212)
12. Hiromatsu Y, Kakau H, Mukai T i wsp. Immunohistochemi-cal analysis of Bcl-2, Bax and Bak expression in thyroid glands from patients with Graves' disease. Endocrinol J 2004; 51: 399-405. (Pubitemid 39273450)
13. Bryl E, Vallejo AN, Weyend CM i wsp. Down-regulation of CD28 expression by TNF-alpha. J Immunol 2001; 167: 3231-3238.
14. Jiang J, Anaraki F, Blank KJ i wsp. Cutting edge: T cells from aged mice are resistant to depletion early during virus infection. J Immunol 2003; 171: 3353-3347.
15. Zhou T, Edwards CK, Mountz JD. Prevention of age related T-cell apoptosis defect in CD2-fas-transgenic mice. J Exp Med 1995; 182: 129-137.
16. Hsu HC, Zhou T, Yang PA i wsp. Increased acute phase response and renal amyloidosis in aged CD-2-fas-transgenic mice. J Immunol 1997; 158: 5988-5996. (Pubitemid 127484008)
17. Hiromatsu Y, Bednarczuk T, Soyejima E i wsp. Increased serum soluble Fas in patients with Graves' disease. Thyroid 1999; 9: 341-345. (Pubitemid 29206843)
18. Mysliwiec J, Okłota M, Nikołajuk A i wsp. Soluble Fas, Fas li-gand and Bcl-2 in autoimmune thyroid diseases: relation to humoral immune response markers. Adv Med Sc 2006; 61: 119-122.
19. Zhou T, Mountz JD, Kimberly RP. Immunobiology of tumor necrosis factor receptor superfamily. Immunol Res 2002; 26: 323-336. (Pubitemid 35177509)
20. Hsu HC, Shi J, Yang P i wsp. Activated CD8 (+) T cells from aged mice exhibit decreased activation-induced cell death. Mech Ageing Dev 2001; 122: 1663-1684. (Pubitemid 32835215)
21. Pinti M, Troiano L, Nasi M i wsp. Balanced regulation of mRNA production for Fas and Fas ligand in lymphocytes from centenarians: how the immune system starts its second century. Circulation 2004; 110: 3108-3114. (Pubitemid 39492006)
22. Mitsiades N, Poulaki V, Kotoula V i wsp. Fas/Fas ligand up-regulation and Bcl-2 down-regulation may be significant in the pathogenesis of Hashimoto's thyroiditis. J Clin Endocrinol Metab 1998; 83: 2199-2203. (Pubitemid 28496359)
23. Aggarwal S, Gupta S. Increased apoptosis of T cell subsets in aging humans: altered expression of Fas (CD95), Fas ligand, Bcl-2, and Bax. J Immunol 1998; 160: 1627-1637. (Pubitemid 28106447)